Global COVID-19 Inactivated Vaccine Market Growth (Status and Outlook) 2023-2029

March 2023 | 105 pages | ID: G3E378DE8015EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global COVID-19 Inactivated Vaccine market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Inactivated Vaccine market by product type, application, key players and key regions and countries.

Segmentation by product type:

• In Clinical Trials
• Out-of-Clinical Trials

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Inovio Pharmaceuticals
• Takis Biotech (Evvivax)
• Zydus Cadila
• Codagenix, Inc.
• GeoVax, Inc.
• Bravovax
• Janssen Pharmaceutical Companies
• Altimmune
• Vaxart
• CanSino Biologics
• ExpreS2ion Biotechnologies ApS
• Clover Biopharmaceuticals
• GSK
• Vaxil Bio Ltd.
• Generex
• Novavax, Inc.
• Sanofi Pasteur
• Baylor
• iBio, Inc.
• Moderna, Inc.
• Curevac
• ImmunoPrecise

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 Inactivated Vaccine Market Size 2024-2029
  2.1.2 COVID-19 Inactivated Vaccine Market Size CAGR by Region
2.2 COVID-19 Inactivated Vaccine Segment by Type
  2.2.1 In Clinical Trials
  2.2.2 Out-of-Clinical Trials
2.3 COVID-19 Inactivated Vaccine Market Size by Type
  2.3.1 Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 Inactivated Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 COVID-19 Inactivated Vaccine Market Size by Application
  2.5.1 Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Application (2024-2029)

3 COVID-19 INACTIVATED VACCINE KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 Inactivated Vaccine
3.2 Key Players COVID-19 Inactivated Vaccine Product Offered
3.3 Key Players COVID-19 Inactivated Vaccine Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 INACTIVATED VACCINE BY REGIONS

4.1 COVID-19 Inactivated Vaccine Market Size by Regions (2024-2029)
4.2 United States COVID-19 Inactivated Vaccine Market Size Growth (2024-2029)
4.3 China COVID-19 Inactivated Vaccine Market Size Growth (2024-2029)
4.4 Europe COVID-19 Inactivated Vaccine Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 Inactivated Vaccine Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 Inactivated Vaccine Market Size by Type (2024-2029)
5.2 United States COVID-19 Inactivated Vaccine Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 Inactivated Vaccine Market Size by Type (2024-2029)
6.2 Europe COVID-19 Inactivated Vaccine Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 Inactivated Vaccine Market Size by Type (2024-2029)
7.2 China COVID-19 Inactivated Vaccine Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 Inactivated Vaccine Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 Inactivated Vaccine Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 INACTIVATED VACCINE

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Inovio Pharmaceuticals
  11.1.1 Inovio Pharmaceuticals Company Details
  11.1.2 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product Offered
  11.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.1.4 Inovio Pharmaceuticals Main Business Overview
  11.1.5 Inovio Pharmaceuticals News
11.2 Takis Biotech (Evvivax)
  11.2.1 Takis Biotech (Evvivax) Company Details
  11.2.2 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product Offered
  11.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.2.4 Takis Biotech (Evvivax) Main Business Overview
  11.2.5 Takis Biotech (Evvivax) News
11.3 Zydus Cadila
  11.3.1 Zydus Cadila Company Details
  11.3.2 Zydus Cadila COVID-19 Inactivated Vaccine Product Offered
  11.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.3.4 Zydus Cadila Main Business Overview
  11.3.5 Zydus Cadila News
11.4 Codagenix, Inc.
  11.4.1 Codagenix, Inc. Company Details
  11.4.2 Codagenix, Inc. COVID-19 Inactivated Vaccine Product Offered
  11.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.4.4 Codagenix, Inc. Main Business Overview
  11.4.5 Codagenix, Inc. News
11.5 GeoVax, Inc.
  11.5.1 GeoVax, Inc. Company Details
  11.5.2 GeoVax, Inc. COVID-19 Inactivated Vaccine Product Offered
  11.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.5.4 GeoVax, Inc. Main Business Overview
  11.5.5 GeoVax, Inc. News
11.6 Bravovax
  11.6.1 Bravovax Company Details
  11.6.2 Bravovax COVID-19 Inactivated Vaccine Product Offered
  11.6.3 Bravovax COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.6.4 Bravovax Main Business Overview
  11.6.5 Bravovax News
11.7 Janssen Pharmaceutical Companies
  11.7.1 Janssen Pharmaceutical Companies Company Details
  11.7.2 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product Offered
  11.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.7.4 Janssen Pharmaceutical Companies Main Business Overview
  11.7.5 Janssen Pharmaceutical Companies News
11.8 Altimmune
  11.8.1 Altimmune Company Details
  11.8.2 Altimmune COVID-19 Inactivated Vaccine Product Offered
  11.8.3 Altimmune COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.8.4 Altimmune Main Business Overview
  11.8.5 Altimmune News
11.9 Vaxart
  11.9.1 Vaxart Company Details
  11.9.2 Vaxart COVID-19 Inactivated Vaccine Product Offered
  11.9.3 Vaxart COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.9.4 Vaxart Main Business Overview
  11.9.5 Vaxart News
11.10 CanSino Biologics
  11.10.1 CanSino Biologics Company Details
  11.10.2 CanSino Biologics COVID-19 Inactivated Vaccine Product Offered
  11.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
  11.10.4 CanSino Biologics Main Business Overview
  11.10.5 CanSino Biologics News
11.11 ExpreS2ion Biotechnologies ApS
11.12 Clover Biopharmaceuticals
11.13 GSK
11.14 Vaxil Bio Ltd.
11.15 Generex
11.16 Novavax, Inc.
11.17 Sanofi Pasteur
11.18 Baylor
11.19 iBio, Inc.
11.20 Moderna, Inc.
11.21 Curevac
11.22 ImmunoPrecise

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Inactivated Vaccine Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of In Clinical Trials
Table 3. Major Players of Out-of-Clinical Trials
Table 4. Global COVID-19 Inactivated Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 5. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Table 6. Global COVID-19 Inactivated Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 7. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Table 8. Date of Global Key Players Enter into COVID-19 Inactivated Vaccine Market
Table 9. Global Key Players COVID-19 Inactivated Vaccine Product Offered
Table 10. Key Players COVID-19 Inactivated Vaccine Funding/Investment ($ Millions)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End Industry
Table 13. Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization ($ Millions)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. COVID-19 Inactivated Vaccine New Product/Technology Launches
Table 16. COVID-19 Inactivated Vaccine Industry Partnerships, Agreements, and Collaborations
Table 17. COVID-19 Inactivated Vaccine Industry Mergers and Acquisitions
Table 18. Global COVID-19 Inactivated Vaccine Market Size by Regions 2024-2029 ($ Millions)
Table 19. Global COVID-19 Inactivated Vaccine Market Size Market Share by Regions 2024-2029
Table 20. United States COVID-19 Inactivated Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 21. United States COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Table 22. United States COVID-19 Inactivated Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 23. United States COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Table 24. Europe COVID-19 Inactivated Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 25. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Table 26. Europe COVID-19 Inactivated Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 27. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Table 28. China COVID-19 Inactivated Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 29. China COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Table 30. China COVID-19 Inactivated Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 31. China COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Table 32. Rest of World COVID-19 Inactivated Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 33. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Table 34. Rest of World COVID-19 Inactivated Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 35. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Table 36. Key Market Drivers & Growth Opportunities of COVID-19 Inactivated Vaccine
Table 37. Key Market Challenges & Risks of COVID-19 Inactivated Vaccine
Table 38. Key Industry Trends of COVID-19 Inactivated Vaccine
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Inovio Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 52. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 53. Takis Biotech (Evvivax) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 55. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Zydus Cadila COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 57. Codagenix, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Codagenix, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 59. GeoVax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. GeoVax, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 61. Bravovax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Bravovax COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 63. Janssen Pharmaceutical Companies Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 65. Altimmune Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Altimmune COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 67. Vaxart Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Vaxart COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 69. CanSino Biologics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. CanSino Biologics COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 71. ExpreS2ion Biotechnologies ApS Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 73. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 74. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 75. GSK Basic Information, Head Office, Major Market Areas and Its Competitors
Table 76. GSK COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 77. Vaxil Bio Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 78. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 79. Generex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 80. Generex COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 81. Novavax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 82. Novavax, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 83. Sanofi Pasteur Basic Information, Head Office, Major Market Areas and Its Competitors
Table 84. Sanofi Pasteur COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 85. Baylor Basic Information, Head Office, Major Market Areas and Its Competitors
Table 86. Baylor COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 87. iBio, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 88. iBio, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 89. Moderna, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 90. Moderna, Inc. COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 91. Curevac Basic Information, Head Office, Major Market Areas and Its Competitors
Table 92. Curevac COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)
Table 93. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors
Table 94. ImmunoPrecise COVID-19 Inactivated Vaccine Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of COVID-19 Inactivated Vaccine
Figure 2. COVID-19 Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 Inactivated Vaccine Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 Inactivated Vaccine Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2024-2029)
Figure 9. Global In Clinical Trials Market Size Growth Rate
Figure 10. Global Out-of-Clinical Trials Market Size Growth Rate
Figure 11. COVID-19 Inactivated Vaccine in Hospital
Figure 12. Global COVID-19 Inactivated Vaccine Market: Hospital (2024-2029) ($ Millions)
Figure 13. COVID-19 Inactivated Vaccine in Clinic
Figure 14. Global COVID-19 Inactivated Vaccine Market: Clinic (2024-2029) ($ Millions)
Figure 15. COVID-19 Inactivated Vaccine in Other
Figure 16. Global COVID-19 Inactivated Vaccine Market: Other (2024-2029) ($ Millions)
Figure 17. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2024-2029)
Figure 18. Global COVID-19 Inactivated Vaccine Market Size in Hospital Growth Rate
Figure 19. Global COVID-19 Inactivated Vaccine Market Size in Clinic Growth Rate
Figure 20. Global COVID-19 Inactivated Vaccine Market Size in Other Growth Rate
Figure 21. Funding/Investment
Figure 22. Global COVID-19 Inactivated Vaccine Market Size Market Share by Regions 2024-2029
Figure 23. United States COVID-19 Inactivated Vaccine Market Size 2024-2029 ($ Millions)
Figure 24. China COVID-19 Inactivated Vaccine Market Size 2024-2029 ($ Millions)
Figure 25. Europe COVID-19 Inactivated Vaccine Market Size 2024-2029 ($ Millions)
Figure 26. Rest of World COVID-19 Inactivated Vaccine Market Size 2024-2029 ($ Millions)
Figure 27. United States COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2029
Figure 28. United States COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2029
Figure 29. China COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2029
Figure 30. China COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2029
Figure 31. Europe COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2029
Figure 32. Europe COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2029
Figure 33. Rest of World COVID-19 Inactivated Vaccine Consumption Market Share by Type in 2029
Figure 34. Rest of World COVID-19 Inactivated Vaccine Market Size Market Share by Application in 2029